Literature DB >> 30143819

Elevated CA-125 in IgG4 mesenteritis: a red herring or a disease biomarker? Case report and literature review.

Mailis Michaud Maturana1, Ismini Panayotidis1, Savvas Psarelis2,3, George Nakos4, Elena Nikiphorou5,6.   

Abstract

Mesenteric panniculitis (MP) is a rare chronic disease characterized by inflammation and subsequently fibrosis of adipose tissue of the omentum. Only recently it has been associated with IgG4-related disease. Cancer antigen 125 (CA-125) is a high-molecular mass glycoprotein, traditionally associated with ovarian cancer, although it can be elevated in other conditions. Herein we describe a case of a 56-year-old man with IgG4 related mesenteric panniculitis associated with very high levels of CA-125 at the onset of disease. The CA-125 levels corresponded to clinical disease activity and improved with steroid therapy and rituximab. A literature review was performed concerning possible association of MP, IgG4-related disease and CA-125. The review of literature suggests that high levels of CA-125 can be raised in non-malignant, inflammatory conditions including IgG4-related mesenteritis and can improve with treatment.

Entities:  

Keywords:  Biomarkers, tumor; CA-125 antigen; Immunoglobulin G; Inflammation; Mesentery; Panniculitis, peritoneal; Peritoneum

Mesh:

Substances:

Year:  2018        PMID: 30143819     DOI: 10.1007/s00296-018-4145-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Ascites and a raised serum Ca 125--confusing combination.

Authors:  L B Silberstein; A N Rosenthal; S W Coppack; K Noonan; I J Jacobs
Journal:  J R Soc Med       Date:  2001-11       Impact factor: 5.344

Review 2.  IgG4-related disease.

Authors:  John H Stone; Yoh Zen; Vikram Deshpande
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

3.  Benign causes of increased serum CA-125 concentration.

Authors:  Alper Sevinc; Mustafa Adli; Mehmet Emin Kalender; Celalettin Camci
Journal:  Lancet Oncol       Date:  2007-12       Impact factor: 41.316

4.  The role of CA125 in clinical practice.

Authors:  E L Moss; J Hollingworth; T M Reynolds
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

5.  IgG4-related lung disease with atypical CT imaging: a case report.

Authors:  Jiaxuan Zhou; Xian Li; Qingsi Zeng
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

6.  Regional portal hypertension, systemic lymphadenopathy, and splenomegaly associated with autoimmune pancreatitis.

Authors:  Xiaofei Cheng; Dongkai Zhou; Jianfeng Wei; Shusen Zheng
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-01-18       Impact factor: 2.947

7.  Sclerosing Mesenteritis: A Rare Cause of Small Bowel Obstruction.

Authors:  Glenn Harvin; Adam Graham
Journal:  Case Rep Gastroenterol       Date:  2016-05-19

8.  Clinical and pathological characteristics of IgG4-related interstitial lung disease.

Authors:  Xiaoting Lv; Feng Gao; Qicai Liu; Sheng Zhang; Zhihua Huang; Yongping Zhu; Haiyang Zong; Quwen Li; Sanyan Li
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

9.  Sclerosing mesenteritis and mesenteric panniculitis - clinical experience and radiological features.

Authors:  Lisa Nyberg; Jan Björk; Peter Björkdahl; Olle Ekberg; Klas Sjöberg; Lina Vigren
Journal:  BMC Gastroenterol       Date:  2017-06-13       Impact factor: 3.067

10.  Serum trypsin and TCR as novel markers for predicting disease activity in IgG4-related disease.

Authors:  Wang Fengqing; Yi Qiang; Gao Feng; Zhuang Zehao; Ma Yuefei; Chen Jing; Wang Guina; Hu Bing; Zheng Jing; Zhang Jingjing; Lu Danfeng; Ha Rui; Liu Qi-Cai
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

View more
  1 in total

1.  Severe adenomyosis with unexpectedly high CA-125: report of a rare case.

Authors:  Ibrahim A Abdelazim; Mohannad AbuFaza; Mohamed E S Hamed; Yerbol Bekmukhambetov; Gulmira Zhurabekova; Svetlana Shikanova
Journal:  Prz Menopauzalny       Date:  2020-10-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.